| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |